Characteristics of patients
| No. patients | 55 |
| Age, y | |
| Median | 65 |
| Range | 42-86 |
| No. (%) patients aged 65 y or older | 20 (36.4) |
| Sex | |
| Male | 27 |
| Female | 28 |
| ATL subtype | |
| Acute | 36 |
| Chronic | 12 |
| Lymphoma | 7 |
| WBC (/μL) | |
| Median | 22 900 |
| Range | 3600-199 700 |
| Abnormal lymphocytes (/μL) | |
| Median | 10 730 |
| Range | 0-171 742 |
| LDH (IU/L) | |
| Median | 1117 |
| Range | 210-20 444 |
| Hypercalcemia | |
| No | 41 |
| Yes | 14 |
| BUN* | |
| Normal | 36 |
| High | 10 |
| PS | |
| 0 | 13 |
| 1 | 20 |
| 2 | 10 |
| 3 | 2 |
| 4† | 10 |
| No. patients | 55 |
| Age, y | |
| Median | 65 |
| Range | 42-86 |
| No. (%) patients aged 65 y or older | 20 (36.4) |
| Sex | |
| Male | 27 |
| Female | 28 |
| ATL subtype | |
| Acute | 36 |
| Chronic | 12 |
| Lymphoma | 7 |
| WBC (/μL) | |
| Median | 22 900 |
| Range | 3600-199 700 |
| Abnormal lymphocytes (/μL) | |
| Median | 10 730 |
| Range | 0-171 742 |
| LDH (IU/L) | |
| Median | 1117 |
| Range | 210-20 444 |
| Hypercalcemia | |
| No | 41 |
| Yes | 14 |
| BUN* | |
| Normal | 36 |
| High | 10 |
| PS | |
| 0 | 13 |
| 1 | 20 |
| 2 | 10 |
| 3 | 2 |
| 4† | 10 |